Correlation Between V Tac and GeneReach Biotechnology

Can any of the company-specific risk be diversified away by investing in both V Tac and GeneReach Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining V Tac and GeneReach Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between V Tac Technology Co and GeneReach Biotechnology, you can compare the effects of market volatilities on V Tac and GeneReach Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in V Tac with a short position of GeneReach Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of V Tac and GeneReach Biotechnology.

Diversification Opportunities for V Tac and GeneReach Biotechnology

0.42

Correlation Coefficient

V Tac  GeneReach Biotechnology

Very weak diversification

The 3 months correlation between 6229 and GeneReach is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding V Tac Technology Co and GeneReach Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneReach Biotechnology and V Tac is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on V Tac Technology Co are associated (or correlated) with GeneReach Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneReach Biotechnology has no effect on the direction of V Tac i.e., V Tac and GeneReach Biotechnology go up and down completely randomly.

Pair Corralation between V Tac and GeneReach Biotechnology

Assuming the 90 days trading horizon V Tac Technology Co is expected to under-perform the GeneReach Biotechnology. In addition to that, V Tac is 1.4 times more volatile than GeneReach Biotechnology. It trades about -0.11 of its total potential returns per unit of risk. GeneReach Biotechnology is currently generating about -0.05 per unit of volatility. If you would invest  2,940  in GeneReach Biotechnology on October 10, 2024 and sell it today you would lose (145.00) from holding GeneReach Biotechnology or give up 4.93% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

V Tac Technology Co  vs.  GeneReach Biotechnology

V Tac Technology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days V Tac Technology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

GeneReach Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GeneReach Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, GeneReach Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with V Tac and GeneReach Biotechnology

The main advantage of trading using opposite V Tac and GeneReach Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if V Tac position performs unexpectedly, GeneReach Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneReach Biotechnology will offset losses from the drop in GeneReach Biotechnology's long position.

The idea behind V Tac Technology Co and GeneReach Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.